UnitedHealth Group Incorporated (NYSE:UNH) is Mawer Investment Management Ltd.'s 4th Largest Position

Mawer Investment Management Ltd. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,179,775 shares of the healthcare conglomerate's stock after selling 20,921 shares during the period. UnitedHealth Group makes up about 5.8% of Mawer Investment Management Ltd.'s holdings, making the stock its 4th largest holding. Mawer Investment Management Ltd. owned about 0.24% of UnitedHealth Group worth $1,274,471,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of UNH. International Assets Investment Management LLC increased its holdings in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Swedbank AB purchased a new stake in UnitedHealth Group during the first quarter worth approximately $1,117,462,000. Lone Pine Capital LLC purchased a new position in UnitedHealth Group in the second quarter valued at approximately $480,903,000. Dimensional Fund Advisors LP boosted its holdings in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock valued at $1,942,956,000 after buying an additional 880,183 shares in the last quarter. Finally, Baillie Gifford & Co. raised its stake in UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate's stock worth $455,281,000 after acquiring an additional 821,050 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the topic of a number of research analyst reports. HSBC cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, October 17th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research note on Wednesday, October 16th. Stephens dropped their target price on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a report on Wednesday, October 16th. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Finally, KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an "overweight" rating and a $675.00 target price for the company. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $615.53.

UnitedHealth Group Price Performance

NYSE UNH traded down $2.58 during trading hours on Monday, reaching $589.65. The company's stock had a trading volume of 2,576,785 shares, compared to its average volume of 3,883,119. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market cap of $542.64 billion, a PE ratio of 38.29, a PEG ratio of 1.74 and a beta of 0.58. The company's 50-day moving average is $582.84 and its two-hundred day moving average is $549.98. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group's quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.56 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.